Capital Fund Management (CFM)
IONS icon

Capital Fund Management (CFM)’s Ionis Pharmaceuticals IONS Stock Holding History

Capital Fund Management (CFM)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,600
Closed -$338K – 1785
2019
Q4 		$338K Sell
5,600
-3,100
-36% -$185K ﹤0.01% 1559
2019
Q3 		$521K Sell
8,700
-10,000
-53% -$652K ﹤0.01% 1242
2019
Q2 		$1.2M Buy
18,700
+16,200
+648% +$1.15M 0.01% 961
2019
Q1 		$203K Buy
+2,500
New +$161K ﹤0.01% 1586
2017
Q1 		– Sell
-4,200
Closed -$201K – 1634
2016
Q4 		$201K Buy
+4,200
New +$166K ﹤0.01% 1577
2016
Q3 		– Sell
-13,000
Closed -$303K – 1673
2016
Q2 		$303K Sell
13,000
-49,600
-79% -$1.6M ﹤0.01% 1327
2016
Q1 		$2.54M Buy
62,600
+58,400
+1,390% +$2.37M 0.02% 637
2015
Q4 		$260K Buy
+4,200
New +$227K ﹤0.01% 1363
2015
Q3 		– Sell
-7,200
Closed -$414K – 1518
2015
Q2 		$414K Sell
7,200
-35,700
-83% -$2.27M 0.01% 1148
2015
Q1 		$2.73M Buy
42,900
+9,700
+29% +$658K 0.04% 504
2014
Q4 		$2.05M Buy
33,200
+20,800
+168% +$1.03M 0.02% 677
2014
Q3 		$481K Sell
12,400
-6,600
-35% -$234K 0.01% 1167
2014
Q2 		$655K Buy
+19,000
New +$598K 0.01% 1110
2013
Q4 		– Sell
-18,000
Closed -$676K – 1732
2013
Q3 		$676K Buy
+18,000
New +$538K 0.01% 1027

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Fund Management (CFM)'s IONS Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its Ionis Pharmaceuticals (IONS) stake by 132% in Q2 2026, buying an estimated $14.1M and bringing the position to 329,554 shares worth $26.1M. The position accounts for 0.12% of the portfolio, ranked #215.

Capital Fund Management (CFM) first reported a position in IONS in Q2 2013 and has held it in 33 quarters since. The position peaked at $26.8M in Q2 2015. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Capital Fund Management (CFM) held 329,554 shares of Ionis Pharmaceuticals worth $26.1M as of Q2 2026.
  • Capital Fund Management (CFM) bought 187,353 Ionis Pharmaceuticals shares in Q2 2026, an estimated $14.1M.
  • Ionis Pharmaceuticals made up 0.12% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #215 holding.
  • Capital Fund Management (CFM) first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
  • Capital Fund Management (CFM)'s Ionis Pharmaceuticals position peaked at $26.8M in Q2 2015.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.